Conflicting objectives in chemotherapy with drug resistance
From MaRDI portal
Publication:1364689
DOI10.1007/BF02458426zbMath0878.92012OpenAlexW4233610995MaRDI QIDQ1364689
M. I. S. Costa, José Luiz Boldrini
Publication date: 28 August 1997
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/bf02458426
Application models in control theory (93C95) Medical applications (general) (92C50) Control/observation systems governed by ordinary differential equations (93C15)
Related Items
A new conceptual framework for the therapy by optimized multidimensional pulses of therapeutic activity. The case of multiple myeloma model, The dynamics of an optimally controlled tumor model: A case study, TUMOR/IMMUNE SYSTEM COMPETITION WITH MEDICALLY INDUCED ACTIVATION/DEACTIVATION, TUMOR/IMMUNE SYSTEM COMPETITION WITH MEDICALLY INDUCED ACTIVATION/DEACTIVATION
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Optimal control for a cancer chemotherapy problem with general growth and loss functions
- Role of optimal control theory in cancer chemotherapy
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- Optimal control analysis in the chemotherapy of IgG multiple myeloma
- Mathematical approaches to optimization of cancer chemotherapy
- Chemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effects
- Drug kinetics and drug resistance in optimal chemotherapy
- Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity
- Some optimal control problems in cancer chemotherapy with a toxicity limit
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells